Javascript must be enabled to continue!
Role of PPAR in Hepatic Carbohydrate Metabolism
View through CrossRef
Tight control of storage and synthesis of glucose during nutritional transitions is essential to maintain blood glucose levels, a process in which the liver has a central role. PPAR is the master regulator of lipid metabolism during fasting, but evidence is emerging for a role of PPAR in balancing glucose homeostasis as well. By using PPAR ligands and PPAR mice, several crucial genes were shown to be regulated by PPAR in a direct or indirect way. We here review recent evidence that PPAR contributes to the adaptation of hepatic carbohydrate metabolism during the fed-to-fasted or fasted-to-fed transition in rodents.
Title: Role of PPAR in Hepatic Carbohydrate Metabolism
Description:
Tight control of storage and synthesis of glucose during nutritional transitions is essential to maintain blood glucose levels, a process in which the liver has a central role.
PPAR is the master regulator of lipid metabolism during fasting, but evidence is emerging for a role of PPAR in balancing glucose homeostasis as well.
By using PPAR ligands and PPAR mice, several crucial genes were shown to be regulated by PPAR in a direct or indirect way.
We here review recent evidence that PPAR contributes to the adaptation of hepatic carbohydrate metabolism during the fed-to-fasted or fasted-to-fed transition in rodents.
Related Results
Prostaglandin J2 causes dedifferentiation via PPAR‐gamma‐dependent pathway, but not COX‐2 expression in articular chondrocyte.
Prostaglandin J2 causes dedifferentiation via PPAR‐gamma‐dependent pathway, but not COX‐2 expression in articular chondrocyte.
The peroxisome proliferator‐activated receptors(PPARs) represent a family of nuclear receprtor ligand activated transcription factors that have been implicated in maintenance of li...
Cometary Physics Laboratory: spectrophotometric experiments
Cometary Physics Laboratory: spectrophotometric experiments
<p><strong><span dir="ltr" role="presentation">1. Introduction</span></strong&...
Pioglitazone Reduces Secondary Brain Damage after Experimental Brain Trauma by PPAR-γ-Independent Mechanisms
Pioglitazone Reduces Secondary Brain Damage after Experimental Brain Trauma by PPAR-γ-Independent Mechanisms
Inflammatory and ischemic processes contribute to the development of secondary brain damage after mechanical brain injury. Recent data suggest that thiazolidinediones (TZDs), a cla...
Activation of peroxisome proliferator-activated receptor-γ potentiates pro-inflammatory cytokine production, and adrenal and somatotropic changes of weaned pigs after Escherichia coli lipopolysaccharide challenge
Activation of peroxisome proliferator-activated receptor-γ potentiates pro-inflammatory cytokine production, and adrenal and somatotropic changes of weaned pigs after Escherichia coli lipopolysaccharide challenge
Our previous study demonstrated mRNA and protein expression of peroxisome proliferator-activated receptor-g (PPAR-g) in the immune system of weaned pigs. In this report, to test th...
Management of childhood esophageal varices: learnings from an advanced medical centre
Management of childhood esophageal varices: learnings from an advanced medical centre
Background: Variceal bleeding represents a significant clinical emergency with potential life-threatening implications in infants and children. Endoscopic band ligation is the stan...
Differential effects of systemic immune inflammation indices on hepatic steatosis and hepatic fibrosis: evidence from NHANES 1999-2018
Differential effects of systemic immune inflammation indices on hepatic steatosis and hepatic fibrosis: evidence from NHANES 1999-2018
Abstract
Background
Several studies have demonstrated that systemic immune inflammation index (SII) has a positive relationship with hepatic steatosis. However, it is lack...
Should We Use PPAR Agonists to Reduce Cardiovascular Risk?
Should We Use PPAR Agonists to Reduce Cardiovascular Risk?
Trials of peroxisome proliferator‐activated receptor (PPAR) agonists have shown mixed results for cardiovascular prevention. Fibrates are PPAR‐α agonists that act primarily to imp...
Ozone autohemotherapy elevates PPAR-γ expression to lower blood lipid in treatment for psoriasis
Ozone autohemotherapy elevates PPAR-γ expression to lower blood lipid in treatment for psoriasis
Abstract
Background: Psoriasis is widely accepted as a metabolic syndrome with significantly abnormal lipid metabolism and high blood lipids keep patients in a persistent l...

